Log In
BCIQ
Print this Print this
 

SDS-19CAR

  Manage Alerts
Collapse Summary General Information
Company Innovative Cellular Therapeutics Co. Ltd.
Description CD19-targeted chimeric antigen receptor T-cell (CAR-T) therapy
Molecular Target CD19
Mechanism of Action 
Therapeutic ModalityCell therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today